Home / Recalls / KVK-Tech, Inc. / D-1031-2014

D-1031-2014 Class II Terminated

Recalled by KVK-Tech, Inc. — Newtown, PA

Recall Details

Product Type
Drugs
Report Date
January 29, 2014
Initiation Date
December 11, 2013
Termination Date
August 3, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
249,096 bottles

Product Description

HydrOXYzine HCI Tablets USP 25 mg, 100, 500, and 1000 count bottles, Rx only. Mfd by: KVK-TECH, INC, Newtown, PA 18940. 100 count NDC: 10702-011-01, 500 count NDC: 10702-011-50, 1000 count NDC: 10702-011-10.

Reason for Recall

Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.

Distribution Pattern

Nationwide, including Puerto Rico to wholesale distributors for sale to retail establishments.

Code Information

NDC: 10702-011-01: lot #10666, exp. Feb-14; lot #10733, exp. May-14; lot # 10789, exp.May-14; lot #10790, exp. Jun-14; lot # 10791, exp. Jun-14: lot # 10792, exp. Aug-14; lot #10983, exp. Sep-14; lot #10984, exp.Sep-14; lot #10986, exp. Oct-14; lot # 11034, exp. Nov-14; lot #11035, exp. Dec-14; lot # 11036, exp. Dec-14; lot #11435, exp. Nov-15. NDC: 10702-011-10: lot #10666, exp. Feb-14; lot #10733, exp. May-14; lot #10789, exp. May-14; lot #10790, exp. Jun-14; lot #10791, exp. Jun-14; lot #10792, exp. Aug-14; lot # 10983, exp. Sep-14; lot #10985, exp. Oct-14; lot #11034, exp. Nov-14; lot #11038, exp. Dec-14; lot #11435, exp. Nov-15. NDC: 10702-011-50: lot #10666, exp. Feb-14; lot #10733, exp. May-14; lot # 10789, exp. May-14; lot #10791, exp. Jun-14; lot# 10792, exp. Aug-14; lot # 10983, exp. Sep-14; lot # 10985, exp. Oct-14; lot # 10986, exp. Oct-14; lot # 11037, exp. Dec-14; lot #11435, exp. Nov-15.

Other recalls by KVK-Tech, Inc.

  • D-0049-2024 Class I — Betaxolol Tablets, USP 10 mg, Rx Only, 100 count bottles, Mfd by: KVK Tech Inc., (September 20, 2023)
  • D-0772-2021 Class I — Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd. By: K (July 2, 2021)
  • D-0386-2021 Class III — Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, (April 27, 2021)
  • D-0224-2021 Class III — Benzhydrocodone and Acetaminophen Tablets, CII, 6.12mg/ 325mg, 100 Tablets, Rx O (December 18, 2020)
  • D-0532-2020 Class II — Hydrocodone Bitartrate and Homatropine Methlybromide Oral Solution 5 mg/1.5 mg p (November 1, 2019)
  • D-0142-2020 Class III — Methylphenidate Hydrochloride Oral Solution 5mg per 5mL, 500 mL Bottle, Sugar Fr (October 4, 2019)
  • D-0340-2019 Class II — Oxybutynin Chloride Tablets, USP, 5 mg, 500-count bottle, Rx only, Mfd. By: KVK- (December 11, 2018)
  • D-1083-2017 Class III — Phentermine HCL Capsules, USP 15 mg, packaged in a) 100-count bottles (NDC 10702 (August 3, 2017)
  • D-1057-2016 Class III — Benzphetamine Hydrochloride Tablets, 50 mg, 30-count bottle, RX only, Mfd by: KV (May 5, 2016)
  • D-1371-2015 Class III — Phentermine Hydrochloride Capsules, USP, 15 mg, packaged in a) 100-count bottle (July 14, 2015)